Amylyx Pharmaceuticals, Inc. (AMLX) Misses Q1 EPS by 4c

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) reported Q1 EPS of ($0.37), $0.04 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Amylyx Pharmaceuticals, Inc. (AMLX) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Broadcom (AVGO) Tops Q2 EPS by 5c, Offers Guidance
• Tilly's, Inc. (TLYS) Tops Q1 EPS by 44c ; offer guidance